Article ID Journal Published Year Pages File Type
3393216 Travel Medicine and Infectious Disease 2011 7 Pages PDF
Abstract
The other topic pertains to the results of a study designed to evaluate the safety and immunogenicity of the Japanese DPT vaccine in adults when administered at the dose of 0.2 ml (2/5th of the ordinary dose). In Japan, there is no system for providing advice to adults on vaccination once the childhood schedule is completed. The author, however, wishes to propose here that if the currently approved DPT vaccine can be better utilized as Tdap, we may improve the means for disease prophylaxis.
Keywords
Related Topics
Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology
Authors
,